ALNA - オ―レナ・ファ―マシュ―ティカルズ （Allena Pharmaceuticals Inc.） オ―レナ・ファ―マシュ―ティカルズALNAのチャート
ALNAの企業情報
| symbol | ALNA |
|---|---|
| 会社名 | Allena Pharmaceuticals Inc （オ―レナ・ファ―マシュ―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 アレナ・ファーマスーティカルズ(Allena Pharmaceuticals Inc.)はバイオ医薬品会社である。同社は代謝疾患および孤児性疾患を治療する非全身性経口タンパク質治療薬の開発・製品化に重点を置いて、特に腎臓および泌尿器疾患に重点を置く。リード製品候補のALLN-177は胃腸管の蓚酸塩を標的にして胃酸分泌を減少させるフェーズⅡ臨床試験中であり、高酸素尿症および腎結石の慢性管理のために開発される。ALLN-177はシュウ酸カルシウム関連の合併症の発生率を減少させ、腎臓にシュウ酸カルシウム結晶または結石として堆積するために全身的に利用可能なシュウ酸塩を減少させる可能性がある。同社の技術法は胃腸管に留まる経口タンパク質療法の設計と開発を可能にする。 オ―レナ・ファ―マシュ―ティカルズは米国のバイオ医薬品企業。子会社を通じて、腎臓に影響する代謝異常に注力した経口用酵素治療薬の開発・商用化に従事する。腎臓結石と関連する高シュウ酸尿症の治療薬「ALLN-177」は後期臨床段階である。また、慢性腎臓疾患を緩和する「ALLN-346」も開発中。本社所在地はマサチュ―セッツ州ニュ―トン。 |
| 本社所在地 | One Newton Executive Park Suite 202 Newton MA 02462 USA |
| 代表者氏名 | Louis Brenner ルイス・ブレナー |
| 代表者役職名 | President Chief Operating Officer 社長兼最高執行責任者（COO） |
| 電話番号 | +1 617-467-4577 |
| 設立年月日 | 40695 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2017年 |
| 従業員数 | 37人 |
| url | www.allenapharma.com |
| nasdaq_url | https://www.nasdaq.com/symbol/alna |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -26.97500 |
| 終値（lastsale） | 10.28 |
| 時価総額（marketcap） | 213332276.76 |
| 時価総額 | 時価総額（百万ドル） 215.61500 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 146.74100 |
| 当期純利益 | 当期純利益（百万ドル） -27.89700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Allena Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased 60% to $16.5M. Higher net loss reflects Research_Development - Balancing value increase of 49% to $11.6M (expense) General and Administrative - Balancing. increase of 76% to $3.6M (expense) Stock-based Compensation in SGA increase from $139K to $682K (expense). |
ALNAのテクニカル分析
ALNAのニュース
RETA, ALNA and BSGM among mid-day movers 2022/09/07 17:28:34 Seeking Alpha
Gainers: IMARA IMRA +61%.Allena Pharmaceuticals (ALNA) +49%.Azure Power Global (AZRE) +32%.SelectQuote SLQT +26%.Shuttle Pharmaceuticals SHPH +25%.Glaukos GKOS +25%.Sidus…
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday''s Mid-Day Session 2022/09/07 16:22:21 Benzinga
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 64% … Full story available on Benzinga.com
Thinking about buying stock in Allena Pharmaceuticals, Spero Therapeutics, Signify Health, Avaya Holdings, or Frontline? 2022/09/06 18:32:00 Benzinga
NEW YORK , Sept. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALNA, SPRO, SGFY, AVYA, and FRO. … Full story available on Benzinga.com
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy 2022/09/06 11:06:56 Benzinga
Full story available on Benzinga.com
Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? 2022/09/02 14:30:00 Stocks Register
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) concluded the trading at $0.10 on Thursday, September 01 with a fall of -2.47% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.11 and 5Y monthly beta was reading 1.42 with its price kept floating in the … Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? Read More »
RETA, ALNA and BSGM among mid-day movers 2022/09/07 17:28:34 Seeking Alpha
Gainers: IMARA IMRA +61%.Allena Pharmaceuticals (ALNA) +49%.Azure Power Global (AZRE) +32%.SelectQuote SLQT +26%.Shuttle Pharmaceuticals SHPH +25%.Glaukos GKOS +25%.Sidus…
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday''s Mid-Day Session 2022/09/07 16:22:21 Benzinga
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) jumped 64% … Full story available on Benzinga.com
Thinking about buying stock in Allena Pharmaceuticals, Spero Therapeutics, Signify Health, Avaya Holdings, or Frontline? 2022/09/06 18:32:00 Benzinga
NEW YORK , Sept. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALNA, SPRO, SGFY, AVYA, and FRO. … Full story available on Benzinga.com
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy 2022/09/06 11:06:56 Benzinga
Full story available on Benzinga.com
Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? 2022/09/02 14:30:00 Stocks Register
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) concluded the trading at $0.10 on Thursday, September 01 with a fall of -2.47% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.11 and 5Y monthly beta was reading 1.42 with its price kept floating in the … Allena Pharmaceuticals Inc. (ALNA) Rises From The Low: Could It Be A Catbird Seat? Read More »
Bright Trending Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Rio Tinto Group (NYSE:RIO) 2022/02/23 03:17:40 Stock Equity
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -5.30% also noticed, India Rio Tinto Group (NYSE:RIO) encountered a rapid change of 0.18% in the last hour of Tuesdays trading session. The post Bright Trending Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Rio Tinto Group (NYSE:RIO) appeared first on Stocks Equity .
Allena Pharmaceuticals Inc Shares Approach 52-Week Low - Market Mover 2022/01/14 05:09:59 Kwhen Finance
Allena Pharmaceuticals Inc (ALNA) shares closed today at 0.4% above its 52 week low of $0.46, giving the company a market cap of $39M. The stock is currently down 19.2% year-to-date, down 65.5% over the past 12 months, and down 95.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 58.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 533.5% The company's stock price performance over the past 12 months lags the peer average by 114.8%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days 2022/01/08 05:36:25 Seeking Alpha
Traders should divert their intention on this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Galiano Gold Inc. (AMEX:GAU) 2021/12/24 04:46:20 Stock Equity
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -0.41% also noticed, India Galiano Gold Inc. (AMEX:GAU) encountered a rapid change of 0.63% in the last hour of Thursdays trading session. The post Traders should divert their intention on this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Galiano Gold Inc. (AMEX:GAU) appeared first on Stocks Equity .
Allena Pharmaceuticals (NASDAQ:ALNA) Upgraded by Zacks Investment Research to Buy 2021/12/22 07:46:42 Dakota Financial News
Zacks Investment Research upgraded shares of Allena Pharmaceuticals (NASDAQ:ALNA) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. The brokerage currently has $0.75 price target on the stock. According to Zacks, Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral []